Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis.

Literature DB >> 22895789

Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis.

Ying Zhang¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Metronidazole

Year: 2012 PMID： 22895789 PMCID： PMC3435169 DOI： 10.1073/pnas.1211081109

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

20 in total

1. Metronidazole therapy in mice infected with tuberculosis.

Authors: J V Brooks; S K Furney; I M Orme
Journal: Antimicrob Agents Chemother Date: 1999-05 Impact factor: 5.191

2. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques.

Authors: Philana Ling Lin; Veronique Dartois; Paul J Johnston; Christopher Janssen; Laura Via; Michael B Goodwin; Edwin Klein; Clifton E Barry; Joanne L Flynn
Journal: Proc Natl Acad Sci U S A Date: 2012-07-23 Impact factor: 11.205

3. Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.

Authors: Eric Nuermberger; Sandeep Tyagi; Rokeya Tasneen; Kathy N Williams; Deepak Almeida; Ian Rosenthal; Jacques H Grosset
Journal: Antimicrob Agents Chemother Date: 2008-02-19 Impact factor: 5.191

4. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates.

Authors: Laura E Via; P Ling Lin; Sonja M Ray; Jose Carrillo; Shannon Sedberry Allen; Seok Yong Eum; Kimberly Taylor; Edwin Klein; Ujjini Manjunatha; Jacqueline Gonzales; Eun Gae Lee; Seung Kyu Park; James A Raleigh; Sang Nae Cho; David N McMurray; JoAnne L Flynn; Clifton E Barry
Journal: Infect Immun Date: 2008-03-17 Impact factor: 3.441

5. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Authors: Susan E Dorman; John L Johnson; Stefan Goldberg; Grace Muzanye; Nesri Padayatchi; Lorna Bozeman; Charles M Heilig; John Bernardo; Shurjeel Choudhri; Jacques H Grosset; Elizabeth Guy; Priya Guyadeen; Maria Corazon Leus; Gina Maltas; Dick Menzies; Eric L Nuermberger; Margarita Villarino; Andrew Vernon; Richard E Chaisson
Journal: Am J Respir Crit Care Med Date: 2009-04-30 Impact factor: 21.405

6. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency.

Authors: Lee G Klinkenberg; Lesley A Sutherland; William R Bishai; Petros C Karakousis
Journal: J Infect Dis Date: 2008-07-15 Impact factor: 5.226

7. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors: L G Wayne; H A Sramek
Journal: Antimicrob Agents Chemother Date: 1994-09 Impact factor: 5.191

8. Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

Authors: Eric L Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; Kathy Williams; Ian Rosenthal; Richard J O'Brien; Andrew A Vernon; Richard E Chaisson; William R Bishai; Jacques H Grosset
Journal: Am J Respir Crit Care Med Date: 2004-08-11 Impact factor: 21.405